Haolong is a leader and role model on his research team. He has mentored other trainees including visiting scholars, junior graduate students and undergraduate co-op students. His research examines improving drug treatments for prostate cancer, and he has also been recognized for his academic achievements, including prolific publishing of first-author peer-reviewed papers during his PhD.
“One in eight Canadian men will be affected by prostate cancer in their lifetime,” explains Haolong. “I hope our study can provide a potential therapeutic strategy for drug-resistant prostate cancer that may eventually benefit patient survival.”